Development of pancytopenia after single low-dose methotrexate therapy in patients with chronic kidney disease: a review of the literature
Methotrexate (MTX) is widely used in the treatment of both rheumatoid arthritis (RA) and psoriatic arthritis (PA) with a side effect of pancytopenia. However, very few cases of severe pancytopenia caused by low-dose MTX therapy have been described in chronic kidney disease. Pancytopenia occurred aft...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nizameddin KOCA
2020-07-01
|
| Series: | Turkish Journal of Internal Medicine |
| Subjects: | |
| Online Access: | https://dergipark.org.tr/tr/download/article-file/1219248 |